Advertisement
Screener

MiMedx Group, Inc. (MDXG) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent

MiMedx Group, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent

MiMedx Group, Inc. (MDXG) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -4.58% for the 12-month period ending 2015-12-31, per its 10-K filed 2017-02-22.

Discontinued › Expense Statement › Income Tax

us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2017-02-22

  • MiMedx Group, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2015 was -4.58%.
  • MiMedx Group, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2014 was -5.92%, a 146.50% decline from fiscal 2013.
  • MiMedx Group, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2013 was 12.73%, a 1858.46% increase from fiscal 2012.
  • MiMedx Group, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2012 was 0.65%.
Period endEffective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 monthEffective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed
2015-12-31-4.58%
10-K · filed 2017-02-22
2014-12-31-5.92%
10-K · filed 2017-02-22
2013-12-3112.73%
10-K · filed 2015-03-13
2012-12-310.65%
10-K · filed 2014-03-04
6.51%
10-K · filed 2013-03-15
2011-12-31-11.30%
10-K · filed 2013-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
SpyGlass Pharma, Inc. (SGP)United States$0.925B